1.5 mm HYDRO LeMaitre Valvulotome, 98 cm, Sterile REF # 1009-00 Product Usage: The HYDRO Le...
FDA Device Recall #Z-2543-2016 — Class II — August 3, 2016
Recall Summary
| Recall Number | Z-2543-2016 |
| Classification | Class II — Moderate risk |
| Date Initiated | August 3, 2016 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | LeMaitre Vascular, Inc. |
| Location | Burlington, MA |
| Product Type | Devices |
| Quantity | 1992 units |
Product Description
1.5 mm HYDRO LeMaitre Valvulotome, 98 cm, Sterile REF # 1009-00 Product Usage: The HYDRO LeMaitre Valvulotome is intended for the treatment of vascular disorders and more particularly for excising or disrupting venous valves
Reason for Recall
Wire which deploys the loop may be come detached at the handle causing the device to be inoperable
Distribution Pattern
Worldwide Distribution - US Nationwide and in the countries of Australia, BELGIUM, BRAZIL, CANADA, Czech Republic, DENMARK, FINLAND, FRANCE, GERMANY, Italy, Japan, NETHERLANDS, Russia, Spain, SWEDEN, Switzerland, and UK.
Lot / Code Information
Lot Number Exp Date ELVH1072V 2020-07 ELVH1082V 2021-01 ELVH1083V 2021-01 ELVH1084V 2021-02 ELVH1085V 2021-02 ELVH1086V 2021-02 ELVH1087V 2021-02 ELVH1088V 2021-03
Other Recalls from LeMaitre Vascular, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1574-2026 | Class II | Artegraft Vascular Graft; REF#: AG740; | Feb 10, 2026 |
| Z-0289-2026 | Class II | Artegraft¿ Collagen Vascular Graft; REF: AG1015; | Sep 25, 2025 |
| Z-0034-2026 | Class II | Artegraft Collagen Vascular Grafts Model Numbe... | Sep 2, 2025 |
| Z-0072-2026 | Class II | Artegraft Collagen Vascular Graft. Model/Catal... | Aug 25, 2025 |
| Z-1751-2025 | Class II | Pruitt Occlusion Catheter. Catalog Numbers: 210... | Apr 11, 2025 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.